O'Lenic brings a wealth of expertise in driving business growth from start-up stages to favorable outcomes, with a strong emphasis on commercial strategy.
Aim to help life sciences companies meet regulatory requirements and standards for quality and safety in the drug development and manufacturing life cycle.
Gao has more than 25 years of experience in leading various functions including finance, audit, investment, project management, compliance and board office.
The clinical lab staff shortage has been an issue in the UK for years. Industry can close the gap and make the field more resilient with careful strategizing.
The ability to monitor biopharma processes in real time provides significant advantages in optimizing product quality with respect to multiple attributes.
Toxicological evaluation is important at every stage of HPAPI development and manufacturing—CDMOs help ensure new treatments are brought to market safely.